The primary objective of the study was met , demonstrating that etoricoxib @mg qd was non-inferior to ibuprofen @mg qid ; further , etoricoxib was statistically superior to ibuprofen @mg qid according to the primary endpoint ( TOPAR@ ) and patient global assessments of study medication .